Loading...

Brilliant Violet 785™ anti-human CD3 Antibody

Pricing & Availability
Clone
OKT3 (See other available formats)
Regulatory Status
RUO
Workshop
HCDM listed
Other Names
T3, CD3ε
Isotype
Mouse IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
OKT3_BV785_061512
Human peripheral lymphocytes were stained with CD3 (clone OKT3) Brilliant Violet 785™.
  • OKT3_BV785_061512
    Human peripheral lymphocytes were stained with CD3 (clone OKT3) Brilliant Violet 785™.
Compare all formats See Brilliant Violet 785™ spectral data
Cat # Size Price Quantity Check Availability Save
317329 25 tests 161€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
317330 100 tests 317€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD chain of the CD3/T cell receptor (TCR) complex, which is composed of two CD3ε, one CD3γ, one CD3δ, one CD3ζ (CD247), and a T cell receptor (α/β or γ/δ) heterodimer. It is found on all mature T lymphocytes, NK T cells, and some thymocytes. CD3, also known as T3, is a member of the immunoglobulin superfamily that plays a role in antigen recognition, signal transduction, and T cell activation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 785™ under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Brilliant Violet 785™ excites at 405 nm and emits at 785 nm. The bandpass filter 780/60 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 785™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

The OKT3 monoclonal antibody reacts with an epitope on the epsilon-subunit within the human CD3 complex.

Clone OKT3 can block the binding of clones SK7 and UCHT1.4 The OKT3 antibody is able to induce T cell activation. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections and activation of T cells. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 317304). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 317326) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Knapp W. 1989. Leucocyte Typing IV. Oxford University Press New York.
  3. Barclay N, et al. 1997. The Leucocyte Antigen Facts Book. Academic Press Inc. San Diego.
  4. Li B, et al. 2005. Immunology 116:487.
  5. Jeong HY, et al. 2008. J. Leuckocyte Biol. 83:755. PubMed
  6. Alter G, et al. 2008. J. Virol. 82:9668. PubMed
  7. Manevich-Mendelson E, et al. 2009. Blood 114:2344. PubMed
  8. Pinto JP, et al. 2010. Immunology. 130:217. PubMed
  9. Biggs MJ, et al. 2011. J. R. Soc. Interface. 8:1462. PubMed
Product Citations
  1. Vamva E, et al. 2023. Mol Ther Methods Clin Dev. 28:366. PubMed
  2. Ivarsson M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.50. PubMed
  3. Robinson GA, et al. 2021. EBioMedicine. 103243:. PubMed
  4. Tatari N, et al. 2022. Front Immunol. 13:905768. PubMed
  5. Woan KV, et al. 2021. Cell Stem Cell. 28:2062. PubMed
  6. Wu X, et al. 2022. Front Immunol. 13:811551. PubMed
  7. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  8. Arce Vargas F et al. 2018. Cancer cell. 33(4):649-663 . PubMed
  9. Novakova L et al. 2018. Journal of neurochemistry. 146(3):322-332 . PubMed
  10. Zhou R, et al. 2020. Immunity. S1074-7613(20)30333-2.. PubMed
  11. Leeansyah E, et al. 2015. PLoS Pathog. 11: 1005072. PubMed
  12. Karim F, et al. 2021. Elife. 10:. PubMed
  13. Myers JA, et al. 2022. JCI Insight. :. PubMed
  14. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  15. Asowata OE, et al. 2021. JCI Insight. 6:. PubMed
  16. Ollé Hurtado M, et al. 2019. PLoS One. 14:e0216373. PubMed
  17. Björklund &, et al. 2016. Nat Immunol. 17:451-460. PubMed
  18. Wang N, et al. 2021. iScience. 24:103205. PubMed
  19. Jackson E, et al. 2017. PLoS One. 10.1371/journal.pone.0185160. PubMed
  20. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  21. Fisher J, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.03.002. PubMed
  22. Jin Y et al. 2019. Nature communications. 10(1):391 . PubMed
  23. Neff CP et al. 2018. EBioMedicine. 30:192-202 . PubMed
  24. Caduff N, et al. 2021. Cell Reports. 35(5):109056. PubMed
  25. Davis JE, et al. 2021. J Transl Med. 19:473. PubMed
  26. Nel I, et al. 2021. Diabetologia. 64(10):2306-2321. PubMed
  27. Wu X, et al. 2018. J Immunol Methods. 455:71. PubMed
  28. Moore T,et al. 2017. Cancer Immunol Immunother. . 10.1007/s00262-017-2073-0. PubMed
  29. Huber JE, et al. 2020. J Immunol. 204:1101. PubMed
  30. Li N, et al. 2021. Cell Rep Med. 2:100297. PubMed
  31. Waddington KE, et al. 2020. Front Immunol. 1.51875. PubMed
  32. Isitman G, et al. 2016. PLoS One. 11:e0164517. PubMed
  33. Thieme CJ, et al. 2020. Cell Rep Med. 1:100092. PubMed
  34. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  35. Singh A, et al. 2020. Cell Rep. 32:108153. PubMed
  36. Bradley D, et al. 2022. Nat Commun. 13:5606. PubMed
  37. Menges D, et al. 2022. Nat Commun. 13:4855. PubMed
  38. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  39. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  40. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  41. Martinez EM, et al. 2018. SLAS Discov. 1.377083333. PubMed
  42. Abd Hamid M et al. 2019. Cancer Immunol Res. 7(8):1293-1306 . PubMed
  43. Bruno L, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.49. PubMed
  44. Ferreira-Gomes M, et al. 2021. Nat Commun. 12:1961. PubMed
  45. Ogongo P, et al. 2020. J Clin Invest. 130:214. PubMed
  46. Dersh D, et al. 2020. Immunity. 54(1):116-131.e10. PubMed
RRID
AB_11219196 (BioLegend Cat. No. 317329)
AB_11219196 (BioLegend Cat. No. 317330)

Antigen Details

Structure
Ig superfamily, the subunits CD3γ, CD3δ, CD3ζ (CD247) and TCR (α/β or γ/δ) form the CD3/TCR complex, 20 kD
Distribution

Mature T and NK T cells, thymocyte differentiation

Function
Antigen recognition, signal transduction, T cell activation
Ligand/Receptor
Peptide antigen bound to MHC
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References
  1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego.
  2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329.
  3. Lanier L, et al. 1986. J. Immunol. 137:2501.
Gene ID
916 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD3
Specificity Alt (DOES NOT SHOW ON TDS):
CD3
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 06.12.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account